Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125353491 | 12535349 | 1 | I | 20160629 | 20160707 | 20160707 | PER | PHEH2016US016333 | NOVARTIS | 0.00 | M | Y | 0.00000 | 20160707 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125353491 | 12535349 | 1 | PS | PAZOPANIB | PAZOPANIB | 1 | Unknown | U | 22465 | ||||||||||
| 125353491 | 12535349 | 2 | SS | SORAFENIB | SORAFENIB | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125353491 | 12535349 | 1 | Sarcoma |
| 125353491 | 12535349 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125353491 | 12535349 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125353491 | 12535349 | Abdominal pain | |
| 125353491 | 12535349 | Asthenia | |
| 125353491 | 12535349 | Blood pressure increased | |
| 125353491 | 12535349 | Diarrhoea | |
| 125353491 | 12535349 | Dizziness | |
| 125353491 | 12535349 | Drug intolerance | |
| 125353491 | 12535349 | Nausea | |
| 125353491 | 12535349 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |